George D. Yancopoulos
2018
Compensation breakdown
Non-Equity Incentive Plan | $2,510,598 |
---|---|
Option Awards | $21,339,913 |
Salary | $1,130,900 |
Other | $399,718 |
Total | $25,381,129 |
Yancopoulos received $21.3M in option awards, accounting for 84% of the total pay in 2018.
Yancopoulos also received $2.5M in non-equity incentive plan, $1.1M in salary and $399.7K in other compensation.
Rankings
In 2018, George D. Yancopoulos' compensation ranked 86th out of 14,244 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 86 | 99th |
Manufacturing | 24 | 100th |
Chemicals And Allied Products | 9 | 100th |
Drugs | 7 | 100th |
Pharmaceutical Preparations | 4 | 100th |
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2018.
2018
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2018
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
2018
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2018
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019